Gapping down on news: HSOA -8.8% (cautious Street.com article), TLAB -3.4% (downgraded at two firms this morning), NT -3.0% (initiated with a Underperform at Credit Suisse), AU -1.9% (announces preliminary May 2007 revenue), AZN -1.8% (Bloomberg.com report AZN's Brennan seeks New Drugs in acquisitions).
Gapping up on strong earnings/guidance: NSM +9.2% (MXIM +3.4% in sympathy), CAE +5.8%, ZQK +2.6%.. ITC bans the import of future models of 3G handsets incorporating QCOM chipsets: TXN +2.0% (also in sympathy with NSM), QCOM +1.9%, BRCM +1.8%... Other news: AVNR +7.5 (announces both doses of Zenvia meet primary endpoint), KMGB +4.6%, EON +2.3% (added to tier-1 firm's buy list), AKAM +1.8% (competitor Limelight IPO opens for trading today, also AKAM upgraded to at WR Hambrecht), DNA +1.5% (upgraded to Buy at Deutsche Bank).
No comments:
Post a Comment